share_log

GreenLight Biosciences Says Rwanda FDA Gave Regulatory Approval To Start Phase I/II Clinical Trial Of COVID-19 Vaccine Candidate

GreenLight Biosciences Says Rwanda FDA Gave Regulatory Approval To Start Phase I/II Clinical Trial Of COVID-19 Vaccine Candidate

綠光生物科學表示,盧旺達 FDA 批准了監管機構批准,開始對 COVID-19 疫苗候選人的I/I期臨床試驗
Benzinga Real-time News ·  2023/02/01 07:27

GreenLight Biosciences Says Rwanda FDA Gave Regulatory Approval To Start Phase I/II Clinical Trial Of COVID-19 Vaccine Candidate

綠光生物科學表示,盧旺達 FDA 批准了監管機構批准,開始對 COVID-19 疫苗候選人的I/I期臨床試驗

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論